|
|
.
See Category: Neoplasms
See Header: Benign carcinoid tumors of the small intestine
ICD-10 (CM) Code and Descriptor
|
D3A.019 |
Benign carcinoid tumor of the small intestine, unspecified portion
|
D3A019 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 59.83%
|
16.50%
|
9.20%
|
5.45%
|
2.97%
|
2.00%
|
1.56%
|
0.73%
|
0.29%
|
0.29%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D3A.019*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
563
|
581
|
|
80053
|
COMPREHEN METABOLIC PANEL |
423
|
423
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
421
|
421
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
398
|
399
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
397
|
10,860
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
306
|
311
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
250
|
256
|
|
J1930
|
LANREOTIDE INJECTION |
217
|
26,040
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
103
|
10,019
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
99
|
99
|
|
71260
|
CT THORAX DX C+ |
71
|
71
|
|
84260
|
ASSAY OF SEROTONIN |
67
|
67
|
|
G1004
|
CDSM NDSC |
46
|
179
|
|
96402
|
CHEMO HORMON ANTINEOPL SQ/IM |
46
|
47
|
|
82565
|
ASSAY OF CREATININE |
46
|
46
|
|
83497
|
ASSAY OF 5-HIAA |
41
|
42
|
|
82728
|
ASSAY OF FERRITIN |
39
|
39
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
38
|
38
|
|
83540
|
ASSAY OF IRON |
33
|
33
|
|
83735
|
ASSAY OF MAGNESIUM |
29
|
29
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D3A.019 related to the following DRG Codes:
393-395
|
